X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-22 | IFF | O'Byrne Kevin | Dir | P - Purchase | $76.05 | +4,500 | 14,196 | +46% | +$342,240 | ||||||
2025-05-19 | IFF | Palau Hernandez Margarita | Dir | P - Purchase | $77.42 | +850 | 2,393 | +55% | +$65,807 | ||||||
2025-05-19 | IFF | Yildiz Beril | CAO, SVP, Controller | S - Sale | $77.34 | -2,400 | 3,321 | -42% | -$185,604 | ||||||
2025-05-19 | IFF | Landsman Stephen N | EVP, GC | P - Purchase | $77.28 | +12,000 | 12,000 | New | +$927,356 | ||||||
2025-05-15 | IFF | Khan Mehmood | Dir | P - Purchase | $75.33 | +4,000 | 4,604 | +662% | +$301,314 | ||||||
| M | 2025-05-08 | IFF | Fyrwald J Erik | CEO | P - Purchase | $73.97 | +25,000 | 73,360 | +52% | +$1,849,254 | |||||
2025-03-05 | IFF | O'Byrne Kevin | Dir | P - Purchase | $80.44 | +6,500 | 8,215 | +379% | +$522,833 | ||||||
2025-03-04 | IFF | Fyrwald J Erik | CEO | P - Purchase | $80.24 | +25,000 | 40,590 | +160% | +$2,005,878 | ||||||
2024-11-11 | IFF | Arora Yuvraj | Pres, Nourish | S - Sale | $91.76 | -5,000 | 3,238 | -61% | -$458,775 | ||||||
| D | 2024-06-13 | IFF | Strzelecki Angela | Pres, Pharma Solutions | S - Sale+OE | $95.66 | -2,588 | 8,539 | -23% | -$247,560 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |